ALS Functional Rating Scale - Revised
ALS Functional Rating Scale - Revised (ALSFRS-R) is a validated rating instrument for monitoring the progression of disability in patients with amyotrophic lateral sclerosis (ALS). It is an updated version of the original ALS Functional Rating Scale, and includes additional measures to provide a more comprehensive assessment of patient function and disability.
Overview[edit | edit source]
The ALSFRS-R consists of 12 questions that evaluate the fine motor, gross motor, bulbar, and respiratory function of patients with ALS. Each question is scored from 0 to 4, with 4 indicating normal function and 0 indicating a severe disability. The total score thus ranges from 0 (most severe disability) to 48 (normal function).
Components of the ALSFRS-R[edit | edit source]
The ALSFRS-R includes the following components:
- Fine motor tasks: This includes tasks such as handwriting, cutting food and handling utensils, and manipulating objects.
- Gross motor tasks: This includes tasks such as turning in bed and adjusting bed clothes, walking, and climbing stairs.
- Bulbar function: This includes speech, salivation, and swallowing.
- Respiratory function: This includes dyspnea, orthopnea, and the ability to breathe deeply and cough.
Each of these components is assessed separately, and the scores are added together to give a total score.
Use in Clinical Practice[edit | edit source]
The ALSFRS-R is used in clinical practice to monitor the progression of disability in patients with ALS. It can be used to track changes over time, and to assess the effectiveness of interventions. It is also used in research settings to measure the impact of new treatments on disease progression.
Limitations[edit | edit source]
While the ALSFRS-R is a valuable tool for assessing disability in patients with ALS, it has some limitations. It is a subjective measure, and may be influenced by factors such as patient mood and motivation. It also does not capture all aspects of disability in ALS, such as cognitive and behavioral changes.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
